Calamos Advisors Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$29.5M |
| 2 |
Mastercard
MA
|
+$22.8M |
| 3 |
Capital One
COF
|
+$21.1M |
| 4 |
Union Pacific
UNP
|
+$19.7M |
| 5 |
Adobe
ADBE
|
+$19.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.28% |
| 2 | Financials | 6.96% |
| 3 | Healthcare | 6.9% |
| 4 | Consumer Discretionary | 6.66% |
| 5 | Communication Services | 5.54% |
Similar funds
Calamos Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.
- Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
- Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
- Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
- Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
- Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
- Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
- Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.
Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.